The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Therapix Biosciences announced interim results from its Phase IIa clinical study at Assuta Medical Center in Israel, suggesting that THX-110, a ...
read more
Cellular Biomedicine Group has initiated its Phase I Clinical Trial of anti-CD20 Chimeric Antigen Receptor T-cell (CAR-T) targeting anti-CD19 treated,...
read more
The FDA has approved KANJINTI™ for all approved indications of the reference product, Herceptin® for HER2-overexpressing adjuvant and metastatic ...
read more
Terns announced the initiation of a Phase 1 clinical trial of TERN-101, a farnesoid X receptor agonist, being developed for the treatment of non-...
read more
Savara announced top line data from a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled formulation of recombinant human GM-CSF, for the...
read more
Tolero announced the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0903, an AXL receptor tyrosine kinase (...
read more
The Lung Cancer Research Foundation (LCRF) announced the awardees of the 2019 LCRF Research Grant on Disparities in Lung Cancer.
read more
MetVital announced the FDA has notified MetVital that it may proceed with its clinical investigation of AEO as a potential treatment for patients with...
read more
The first sub-analysis of renal data from the DECLARE-TIMI 58 trial indicates that dapagliflozin reduced the progression of kidney disease or renal ...
read more
Sesen Bio has completed a successful Type B Pre-BLA meeting regarding the approval path for Vicinium for the treatment of patients with high-risk, BCG...
read more
Astex and Otsuka announced top-line results from the ASCERTAIN phase 3 study evaluating cedazuridine and decitabine fixed-dose combination vs ...
read more
SillaJen announced the first patient has been enrolled in Part 2 of JX594-REN026, a Phase 1b clinical trial of Pexa-Vec in combination with Libtayo®, ...
read more
The FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
read more
The FDA Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved ...
read more
Tolero announced the initiation of the Phase 1b expansion stage of its ongoing Phase 1 study evaluating the investigational agent TP-0903, an AXL ...
read more